Show simple item record

dc.contributor.authorRoux, Leanne
dc.date.accessioned2015-05-29T13:17:28Z
dc.date.available2015-05-29T13:17:28Z
dc.date.issued2014
dc.identifier.urihttp://hdl.handle.net/11394/4234
dc.description>Magister Scientiae - MScen_US
dc.description.abstractHealthcare professionals (HCPs) have a primary role to play in the detection, assessment and spontaneous reporting of adverse drug reactions (ADRs). An improvement of their related knowledge, attitude and practice concerning pharmacovigilance and ADR reporting is vital. The objective of the study was to determine whether or not pharmacovigilance training, provided by a Pharmaceutical Company, would improve HCP’s perceptions and adherence to pharmacovigilance and ADR reporting. A quasi-experimental research design was used. A total of 44 HCPs participated in the study. Participants were divided into two groups: an experimental group that received pharmaceutical training intervention; and a control group that did not receive any training. Using a self-administered questionnaire before and after the training intervention assessed the knowledge, attitudes, and practice of pharmacovigilance and ADR reporting displayed amongst the HCPs.en_US
dc.language.isoenen_US
dc.publisherUniversity of the Western Capeen_US
dc.subjectPharmacovigilanceen_US
dc.subjectHealthcare professionalsen_US
dc.subjectAdverse drug reactionen_US
dc.titlePharmacovigilance: the responsibility of pharmaceutical companies to protect patients from drug-related harmsen_US
dc.typeThesisen_US
dc.rights.holderUniversity of the Western Capeen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record